GIP
VYNT

Granite Investment Partners’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Granite Investment Partners’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-921
Closed -$456K – 316
2015
Q4 		$456K Sell
921
-126
-12% -$91K 0.04% 271
2015
Q3 		$1.23M Buy
1,047
+321
+44% +$491K 0.12% 191
2015
Q2 		$1.28M Sell
726
-11
-1% -$17.1K 0.12% 189
2015
Q1 		$863K Buy
+737
New +$873K 0.07% 244

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Granite Investment Partners's VYNT Position: Q1 2016 in Review

Granite Investment Partners sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2016, closing a stake of 921 shares — an estimated $456K sold.

Granite Investment Partners first reported a position in VYNT in Q1 2015 and held it in 4 quarters. The position peaked at $1.28M in Q2 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q1 2016.

  • Granite Investment Partners reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Granite Investment Partners sold 921 Vyant Bio, Inc. Common Stock shares in Q1 2016, an estimated $456K.
  • Granite Investment Partners first reported a position in Vyant Bio, Inc. Common Stock in Q1 2015 and held it in 4 quarters.
  • Granite Investment Partners's Vyant Bio, Inc. Common Stock position peaked at $1.28M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2016.

Based on Granite Investment Partners's 13F filing for Q1 2016, filed 27 Apr 2016.